image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

TMI Trader Portfolio - December '25

December 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

TP2 slightly underperformed this time despite a couple of very strong performances. Helios rose from 148.5p to 172p. The management is now gunning for >9% EBITDA CAGR and over US$1.3bn in cumulative recurring free cash flow between 2026 and 2030. They’re also pledging to return more than US$400m to shareholders through buybacks and dividends by 2030. Add in a hefty Q3 leverage reduction (4.2x → 3.6x) and a sharp re-rating looks entirely on the cards.    Hunting too turned in blistering numbers - EBITDA of US$100.5m versus US$70.2m in H1 - with new tenders rolling in across the Middle East and beyond. Zeus has pencilled in a 450p price target and EPS of 35.4c this year and 40.2c next, implying a soon-to-be prospective PE of just ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe